According to Ojing Medical's announcement, the company was originally scheduled to disclose the third quarter report on October 31, 2026. Due to the heavy data accounting workload, the relevant self-inspection and verification and financial data impact estimation have not yet been completed, so it is expected that it will not be disclosed within the statutory period. The company needs to review the financial data for the previous period, or it may involve correction of prior accounting errors, causing delays in the preparation and review process. The company has extended the disclosure period until December 31, 2026, and reminded investors to be aware of the risks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.